Deep Neural Network Stratification for Use Detecting Endometriosis in Women Affected by Chronic Pelvic Pain (EndoCheck)

Launched by ASPIRA WOMEN'S HEALTH · Feb 8, 2022

Keywords

ClinConnect Summary

The EndoCheck clinical trial is studying a new way to help diagnose endometriosis, a condition that can cause chronic pelvic pain in women. Researchers are testing a special computer program, called a deep neural network, which looks for specific proteins in the body to see if they can help identify endometriosis more accurately. This study aims to show if this method can be a useful tool for doctors when diagnosing this condition.

To participate in this trial, women between the ages of 14 and 50 who are scheduled for surgery to investigate pelvic pain may be eligible. Participants will need to provide written consent and cannot be pregnant or have certain health issues, like active infections or cancers. If you join the study, you can expect to undergo tests related to your surgery, and your information will help researchers understand how well this new diagnostic tool works. This trial is currently recruiting participants and could help improve the way endometriosis is diagnosed in the future.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Participant is willing and able to provide written informed consent.
• • Participant is a female aged 14 to 50 years old at time of consent.
• • Participant is scheduled to undergo laparotomy or laparoscopy for symptomology consistent with possible endometriosis
• Exclusion Criteria:
• • Participant is a female in a pre-menarchal state.
• • Participant is pregnant.
• • Participant has an active malignancy.
• • Participant is known to have tested positive for human immunodeficiency virus or hepatitis A, B, or C.
• • Participant has an active pelvic infection or other infections contraindicated for surgery.
• • Participant has participated (±3 months of study enrollment) in a clinical trial where an investigational drug/ device/ procedure was or is planned to be administered.
• • Participant has any general health or behavioral condition that, in the opinion of the investigator, should exclude the participant from participation.
• • Participant is under 14 years old or over 50 years old